Cellular carriers or free viruses?

Current Opinion in Molecular Therapeutics

Volumn 10, Issue 4, 2008, Pages 321-322

  Seymour, L W ^a   Cawood, R ^a   Fisher, K D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER STEM CELL; CANCER SURVIVAL; CELL POPULATION; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; MICROENVIRONMENT; VIROTHERAPY; VIRUS CARRIER;

GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; VIRUSES;

EID: 49249115744     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Eyler CE, Rich JN: Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol (2008) 26(17):2839-2845.
2. Maitland NJ, Collins AT: Prostate cancer stem cells: A new target for therapy. J Clin Oncol (2008) 26(17):2862-2870.
3. Liu TC, Kirn D: Targeting the untargetable: Oncolytic virotherapy for the cancer stem cell. Mol Ther (2007) 15(12):2060-2061.
4. Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, Harkins R, Hermiston T, Ulbrich K, Fisher KD, Seymour LW: Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther (2004) 11(16):1256-1263.
5. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA: Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet (2005) 366(9502):2019- 2025.
6. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, Fairchild PJ: Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci USA (2007) 104(52):20920-20925.